Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Retained Earnings (2011 - 2025)

Pluri (PLUR) posted quarterly Retained Earnings of -$455.4 million for Q4 2025, down 6.09% year-over-year from -$485.0 million in Q4 2024, and down 1.46% quarter-over-quarter from -$448.9 million in Q3 2025.

Pluri (PLUR) Retained Earnings (2011 - 2025) Analysis & Trends

Pluri (PLUR) has reported Retained Earnings for 15 consecutive years, with -$455.4 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings fell 6.09% year-over-year to -$455.4 million; the TTM figure through Dec 2025 stood at -$455.4 million (down 6.09% YoY), while the FY2025 annual figure was -$443.1 million, down 5.37% from the prior year.
  • Retained Earnings eased to -$455.4 million in Q4 2025 per PLUR's latest filing, from -$448.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $431.0 million in Q1 2025 and bottomed at -$455.4 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$154.6 million across 5 years, with a median of -$369.8 million in 2022.
  • On a YoY basis, Retained Earnings climbed as much as 230.22% in 2021 and fell as far as 210.23% in 2021.
  • Pluri's Retained Earnings stood at $392.2 million in 2021, then grew by 4.2% to $408.7 million in 2022, then tumbled by 200.19% to -$409.4 million in 2023, then decreased by 4.85% to -$429.3 million in 2024, then retreated by 6.09% to -$455.4 million in 2025.
  • Business Quant data shows PLUR's Retained Earnings at -$455.4 million in Q4 2025, -$448.9 million in Q3 2025, and -$443.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 -455.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -455.45 Mn
Sep 30, 2025 -448.91 Mn
Jun 30, 2025 -443.06 Mn
Mar 31, 2025 430.98 Mn
Dec 31, 2024 -429.31 Mn
Sep 30, 2024 -426.35 Mn
Jun 30, 2024 -420.47 Mn
Mar 31, 2024 414.39 Mn
Dec 31, 2023 -409.45 Mn
Sep 30, 2023 413.45 Mn
Jun 30, 2023 -399.58 Mn
Mar 31, 2023 -393.13 Mn
Dec 31, 2022 408.69 Mn
Sep 30, 2022 -377.38 Mn
Jun 30, 2022 401.30 Mn
Mar 31, 2022 -362.26 Mn
Dec 31, 2021 392.23 Mn
Sep 30, 2021 -341.45 Mn
Jun 30, 2021 -330.02 Mn
Mar 31, 2021 -315.45 Mn